KIP Infrastructure
2.12.0 - ci-build

KIP Infrastructure, published by Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S. This guide is not an authorized publication; it is the continuous build for version 2.12.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/KIP-infrastructure/implementation-guide/ and changes regularly. See the Directory of published versions

: ATC DMPN - TTL Representation

Active as of 2022-07-14

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:ValueSet ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "ATCDMPN"] ; # 
  fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet ATCDMPN</b></p><a name=\"ATCDMPN\"> </a><a name=\"hcATCDMPN\"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"CodeSystem-ATC.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/ATC</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-B01AC06\">B01AC06</a></td><td>Acetylsalicylsyre (ASA)</td><td>B01AC06 - acetylsalicylic acid</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01XX35\">L01XX35</a></td><td>Anagrelide</td><td>L01XX35 - anagrelide</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01AB01\">L01AB01</a></td><td>Busulfan (Myleran)</td><td>L01AB01 - busulfan</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01XX05\">L01XX05</a></td><td>Hydroxcarbamid</td><td>L01XX05 - hydroxycarbamide</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-C10AA\">C10AA</a></td><td>Statiner</td><td>C10AA - HMG CoA reductase inhibitors</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01XH\">L01XH</a></td><td>HDAC hæmmer</td><td>L01XH - Histone deacetylase (HDAC) inhibitors</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L03AB\">L03AB</a></td><td>Interferon</td><td>L03AB - Interferons</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L01EJ01\">L01EJ01</a></td><td>Ruxolitinib</td><td>L01EJ01 - ruxolitinib</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-L04AA\">L04AA</a></td><td>JAK-2 inhibitorer</td><td>L04AA - Selective immunosuppressants</td></tr><tr><td><a href=\"CodeSystem-ATC.html#ATC-B01A\">B01A</a></td><td>Anden blodfortyndende behandling</td><td>B01A - ANTITHROMBOTIC AGENTS</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-TreatmentUnspecified.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-TreatmentUnspecified.html#TreatmentUnspecified-incision_vein\">incision_vein</a></td><td>Venesection</td><td>Incision of Vein / Venesektion</td></tr></table></li><li>Include these codes as defined in <a href=\"CodeSystem-GenericValues.html\"><code>https://kip.rkkp.dk/fhir/CodeSystem/GenericValues</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"CodeSystem-GenericValues.html#GenericValues-other\">other</a></td><td>Anden behandling</td><td>Other - used to choose unspecific value not in a valueset</td></tr></table></li></ul></div>"^^rdf:XMLLiteral
  ] ; # 
  fhir:url [ fhir:v "https://kip.rkkp.dk/fhir/ValueSet/ATCDMPN"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "2.12.0"] ; # 
  fhir:name [ fhir:v "ATCDMPN"] ; # 
  fhir:title [ fhir:v "ATC DMPN"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v true] ; # 
  fhir:date [ fhir:v "2022-07-14T00:00:00+02:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S"] ; # 
  fhir:contact ( [
fhir:name [ fhir:v "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S" ] ;
    ( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://trifork.com" ]     ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "rbk@trifork.com" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "ATC koder DMPN behandling. Erstattet af nyt VS fra okt. 2024"] ; # 
  fhir:compose [
    ( fhir:include [
fhir:system [ fhir:v "https://kip.rkkp.dk/fhir/CodeSystem/ATC"^^xsd:anyURI ] ;
      ( fhir:concept [
fhir:code [ fhir:v "B01AC06" ] ;
fhir:display [ fhir:v "Acetylsalicylsyre (ASA)" ]       ] [
fhir:code [ fhir:v "L01XX35" ] ;
fhir:display [ fhir:v "Anagrelide" ]       ] [
fhir:code [ fhir:v "L01AB01" ] ;
fhir:display [ fhir:v "Busulfan (Myleran)" ]       ] [
fhir:code [ fhir:v "L01XX05" ] ;
fhir:display [ fhir:v "Hydroxcarbamid" ]       ] [
fhir:code [ fhir:v "C10AA" ] ;
fhir:display [ fhir:v "Statiner" ]       ] [
fhir:code [ fhir:v "L01XH" ] ;
fhir:display [ fhir:v "HDAC hæmmer" ]       ] [
fhir:code [ fhir:v "L03AB" ] ;
fhir:display [ fhir:v "Interferon" ]       ] [
fhir:code [ fhir:v "L01EJ01" ] ;
fhir:display [ fhir:v "Ruxolitinib" ]       ] [
fhir:code [ fhir:v "L04AA" ] ;
fhir:display [ fhir:v "JAK-2 inhibitorer" ]       ] [
fhir:code [ fhir:v "B01A" ] ;
fhir:display [ fhir:v "Anden blodfortyndende behandling" ]       ] )     ] [
fhir:system [ fhir:v "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentUnspecified"^^xsd:anyURI ] ;
      ( fhir:concept [
fhir:code [ fhir:v "incision_vein" ] ;
fhir:display [ fhir:v "Venesection" ]       ] )     ] [
fhir:system [ fhir:v "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues"^^xsd:anyURI ] ;
      ( fhir:concept [
fhir:code [ fhir:v "other" ] ;
fhir:display [ fhir:v "Anden behandling" ]       ] )     ] )
  ] . #